| Name |
Recombinant Human VSIG3 Fc Chimera Protein, CF
|
| Supplier |
R&D Systems
|
| Catalog |
9229-VS
|
| Category |
Protein
|
| Prices |
$339.00
|
| Sizes |
50 µg
|
| Species Reactivities |
Human
|
| Nature |
Recombinant
|
| Source |
Mouse myeloma cell line, NS0-derived Human VSIG3 (Leu23-Gly245) Accession # BAC07546 IEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus
|
| Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Measured by its ability to inhibit anti-CD3 antibody induced IL-17 secretion by human peripheral blood mononuclear cells (PBMC). The ED 50 for this effect is 1-6 μg/mL.
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| SwissProt/Accession |
BAC07546
|
| Gene |
IGSF11
|
| Sequence |
Leu23
|
| Supplier Page |
Shop
|
Recombinant Human VSIG3 Fc Chimera (Catalog # 9229-VS)inhibits anti-CD3 antibody induced IL-17 secretion in human PBMC. TheED 50 for this effect is 1-6 μg/mL.